All stock lists
OS Therapies Inc (New York Stock Exchange Arca:OSTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.75-$0.12 (-14.00%)
Market cap
$35.1M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 1, 2024
Website
Insider Score
––Not scored
OSTX Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
OSTX analyst forecast
Best analysts covering OSTX
- D. Boral Capital23%success rate · -16.8% avg return · 22 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
OSTX analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Lake Street | Buy | — | — | Reiterated | 2026-05-19 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-04-30 |
OSTX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-31 | -$0.14 | -$0.35 | $0 | $0 |
| 2026-05-18 | -$0.17 | -$0.27 | $971K | $0 |
| 2026-08-14 | -$0.18 | -$0.20 | $750K | $0 |
| 2026-11-13 | -$0.14 | $0.00 | $1.0M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.